IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 83 filers reported holding IGM BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,779,816 | -31.0% | 711,777 | -14.6% | 0.02% | -60.0% |
| Q4 2022 | $14,173,430 | -35.2% | 833,241 | -13.3% | 0.06% | -22.5% |
| Q3 2022 | $21,867,000 | +17.3% | 961,613 | -7.0% | 0.07% | +42.0% |
| Q2 2022 | $18,644,000 | -32.5% | 1,034,035 | 0.0% | 0.05% | -9.1% |
| Q1 2022 | $27,639,000 | +0.4% | 1,034,035 | +10.1% | 0.06% | +7.8% |
| Q4 2021 | $27,542,000 | -55.9% | 939,035 | -1.0% | 0.05% | -51.4% |
| Q3 2021 | $62,393,000 | -28.7% | 948,797 | -9.8% | 0.10% | -18.6% |
| Q2 2021 | $87,479,000 | +8.3% | 1,051,429 | -0.2% | 0.13% | +7.5% |
| Q1 2021 | $80,797,000 | -12.9% | 1,053,552 | +0.2% | 0.12% | -20.5% |
| Q4 2020 | $92,792,000 | +35.4% | 1,050,984 | +13.2% | 0.15% | +18.9% |
| Q3 2020 | $68,555,000 | +24.6% | 928,800 | +23.2% | 0.13% | -8.6% |
| Q2 2020 | $55,028,000 | +102.7% | 753,800 | +55.9% | 0.14% | +19.8% |
| Q1 2020 | $27,154,000 | – | 483,600 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |